Product Information

GLIPIZIDE-METFORMIN 5-500 MG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1961 per EA under NDC 00093745701. Its NADAC has been published 657 times since Nov 28, 2013.

GLIPIZIDE-METFORMIN 5-500 MG

Glipizide and Metformin Hydrochloride
$0.1961per EA

Strength

5; 500 mg/1; mg/1

NDC

00093745701

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA077270

On Market Since

10/28/2005

Pharmacological Classes

Biguanide
Biguanides
Sulfonylurea Compounds
Sulfonylurea

Price Statistics

The NADAC for GLIPIZIDE-METFORMIN 5-500 MG has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 51.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1961 per EA
All-time high$0.5324 (Feb 10, 2016)
All-time low$0.1588 (Jul 21, 2021)
52-week high$0.2224
52-week low$0.1961
Median price$0.2723
Average price$0.3037
Largest weekly change+60.0% (Feb 23, 2022)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-3.8%

3M

-10.3%

6M

-11.2%

1Y

-7.7%

3Y

-27.3%

5Y

+2.2%

All

-51.2%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GLIPIZIDE-METFORMIN 5-500 MG?

The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE-METFORMIN 5-500 MG, manufactured by Teva Pharmaceuticals USA Inc., is $0.1961 per EA (NDC 00093745701), effective Jun 24, 2026.

How has the price of GLIPIZIDE-METFORMIN 5-500 MG changed over time?

Over the history we have for it, the NADAC for GLIPIZIDE-METFORMIN 5-500 MG has declined 51.2%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for GLIPIZIDE-METFORMIN 5-500 MG?

Since Nov 28, 2013, the NADAC for GLIPIZIDE-METFORMIN 5-500 MG has ranged from a low of $0.1588 (Jul 21, 2021) to a high of $0.5324 (Feb 10, 2016), with a median of $0.2723 per EA.

Are there cheaper alternatives to GLIPIZIDE-METFORMIN 5-500 MG?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as GLIPIZIDE-METFORMIN 5-500 MG, but none are currently priced below it.

Who manufactures GLIPIZIDE-METFORMIN 5-500 MG?

GLIPIZIDE-METFORMIN 5-500 MG (NDC 00093745701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.